Journal of Virology · 1998 · 226 citations · 41 references
Life SciencesInfectious DiseasesMolecular BiologyGene ExpressionMolecular VirologyVirologyAntiviral ImmunityInterferon ResponsesViral InfectionsViral PathogenesisVirus-host InteractionsAcute Promyelocytic LeukemiaAntiviral Interferon ResponsesAntiviral Resistance MechanismsAntiviral Signaling PathwaysCoiled-coil DomainsInterference With Interferon SignalingInterferon Response To Viral InfectionPromyelocytic Leukemia Nuclear Bodies
The interferon (IFN)-induced promyelocytic leukemia (PML) protein is specifically associated with nuclear bodies (NBs) whose functions are yet unknown. Two of the NB-associated proteins, PML and Sp100, are induced by IFN. Here we show that overexpression of PML and not Sp100 induces resistance to infections by vesicular stomatitis virus (VSV) (a rhabdovirus) and influenza A virus (an orthomyxovirus) but not by encephalomyocarditis virus (a picornavirus). Inhibition of viral multiplication was dependent on both the level of PML expression and the multiplicity of infection and reached 100-fold. PML was shown to interfere with VSV mRNA and protein synthesis. Compared to the IFN mediator MxA protein, PML had less powerful antiviral activity. While nuclear body localization of PML did not seem to be required for the antiviral effect, deletion of the PML coiled-coil domain completely abolished it. Taken together, these results suggest that PML can contribute to the antiviral state induced in IFN-treated cells.
41
Antibodies, a laboratory manual
Biomedicine & Pharmacotherapy · 1989 · 12.5K citations
Raymond P. Warrell · New England Journal of Medicine · 1993 · 795 citations
Medicine, Hematology, Pharmacology +16